Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
China
· Delayed Price · Currency is CNY 7.32
-0.03 (-0.41%)
Mar 11, 2026, 3:04 PM CST
SHE:002693 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,048 | 7,601 | 3,129 | 3,015 | 1,945 | 1,754 | Upgrade
|
| Market Cap Growth | -52.94% | 142.94% | 3.77% | 55.05% | 10.89% | -7.08% | Upgrade
|
| Enterprise Value | 3,297 | 7,793 | 3,255 | 3,130 | 2,127 | 1,985 | Upgrade
|
| Last Close Price | 7.35 | 18.33 | 7.51 | 7.27 | 4.72 | 4.33 | Upgrade
|
| PE Ratio | - | - | - | 334.55 | - | - | Upgrade
|
| Forward PE | - | 18.69 | 18.69 | 18.69 | 18.69 | 18.69 | Upgrade
|
| PS Ratio | 14.10 | 43.63 | 13.26 | 10.97 | 6.07 | 6.51 | Upgrade
|
| PB Ratio | 7.54 | 18.47 | 6.04 | 5.19 | 3.43 | 2.93 | Upgrade
|
| P/TBV Ratio | 10.71 | 22.66 | 7.47 | 6.83 | 4.83 | 4.09 | Upgrade
|
| P/OCF Ratio | 278.03 | - | 268.82 | 119.56 | 82.56 | - | Upgrade
|
| EV/Sales Ratio | 15.26 | 44.73 | 13.80 | 11.39 | 6.64 | 7.37 | Upgrade
|
| EV/EBITDA Ratio | 153.57 | - | 205.51 | 235.43 | 451.32 | - | Upgrade
|
| EV/FCF Ratio | -430.43 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.72 | 0.67 | 0.36 | 0.38 | 0.31 | 0.37 | Upgrade
|
| Debt / EBITDA Ratio | 13.55 | - | 11.75 | 16.80 | 37.71 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.58 | 0.56 | 0.30 | 0.13 | 0.18 | 0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | 10.99 | -11.89 | 9.73 | 5.82 | 21.36 | -37.51 | Upgrade
|
| Net Debt / FCF Ratio | -30.81 | -3.52 | -4.10 | -9.96 | -12.45 | -1.97 | Upgrade
|
| Asset Turnover | 0.27 | 0.22 | 0.28 | 0.31 | 0.36 | 0.29 | Upgrade
|
| Inventory Turnover | 1.28 | 1.09 | 1.18 | 1.57 | 1.62 | 1.31 | Upgrade
|
| Quick Ratio | 0.44 | 0.41 | 0.43 | 0.58 | 1.01 | 1.06 | Upgrade
|
| Current Ratio | 0.86 | 0.88 | 0.97 | 0.79 | 1.53 | 1.53 | Upgrade
|
| Return on Equity (ROE) | -14.23% | -22.87% | -13.10% | -1.48% | -7.00% | -12.53% | Upgrade
|
| Return on Assets (ROA) | -2.36% | -5.65% | -2.69% | -3.13% | -3.52% | -4.06% | Upgrade
|
| Return on Invested Capital (ROIC) | -4.78% | -10.92% | -5.54% | -6.67% | -7.15% | -8.21% | Upgrade
|
| Return on Capital Employed (ROCE) | -5.20% | -11.80% | -5.60% | -7.50% | -6.60% | -7.80% | Upgrade
|
| Earnings Yield | -1.41% | -1.03% | -1.62% | 0.30% | -1.04% | -3.04% | Upgrade
|
| FCF Yield | -0.25% | -0.86% | -1.20% | -0.26% | -0.42% | -3.54% | Upgrade
|
| Payout Ratio | - | - | - | 123.52% | - | - | Upgrade
|
| Buyback Yield / Dilution | 2.48% | 2.53% | 6.16% | -10.85% | 0.91% | 0.17% | Upgrade
|
| Total Shareholder Return | 2.48% | 2.53% | 6.16% | -10.85% | 0.91% | 0.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.